I have a small interest in this stock and haven't paid much attention within the past month. How does the future look as far as Omontys? Where is this "company" headed. Please, if you are only here to bash then do not respond. I would like an educated, level headed response if possible. Thank you.
Frank, to be honest no one actually knows. Affy as a pharma company is done. They are a shell company and that is the reason they got delisted. Now the only thing everyone is waiting for is the investigation with O. At this point no one has the foggiest idea at the outcome. If it turns out O is the culprit, then goodbye to your investment. It will be worth nothing. On the other hand if it turns out it wasn't O but some other reason and if it's announced O is coming back to the market, then expect a huge huge spike in PPS. At this point noone knows and it's a waiting game. If O comes back, I can see the PPS skyrocketing to double digits very quickly. GLTA
Just to add one more thing. If some predictions are correct and O comes back , every 100 dollar investment could return a 1000, although some claim as much as 2500-3000. On the other hand if O is permanently withdrawn then every 100 dollars will be worth 0. Do your own DD and decide how much risk you are willing to take. Either you will have a massive return or lose everything.
The company has fired all it's employees, they have been taken over by a company that manages bankruptcy. Their drug has been reported to kill people, but it may be the dialysis center. Everyone is waiting for word from takeda as to whether it will be brought back, but that word may take days, weeks or months. In the meantime, one by one people are pulling their money out in search of other opportunities and so the price trickles down.
Invest if you think that the drug has a chance of being returned, in which case the company is worth between 8 and 12 dollars per share, with some people claiming its worth higher. Short if you think it's going to go bankrupt. If it was any more clear, you'd see the market price it in- if it was more likely it was going to return the price would be 3 dollars, and if it were more likely it was going to go bankrupt it would be $0.25.
This is a reasonable assessment that I think we can all agree with. I would only add that 'days, weeks or months' should also include 'years'. I am not sure that Takeda will give any report within 12 months. It is probably a very low priority for them. Who knows what is motivating T? Nobody besides T and probably Orwin-san.
I always have enjoyed Maxdad, the Judas Sheep for AFFY Retail Bagholders. He is classic. After pumping from $1.25 to $2.08 and then leaving as it crashed back to 85 cents. He came back to YMB pumping again when AFFY recovered to a buck so he could lead a new flock of AFFY retail longs to skinning and gutting by his cronies. His GS/JPM hubris and outlandish pumping are pure satire and even funny should you comprehend his Judas Sheep agenda, but are sadly tragic when one considers the many individual financial losses of those who Maxdad persuaded to buy and hold AFFY.
Very funny. An unbiased view from a guy with a ton of LaffyStockQ shares who has spend his entire career at GS/JPM. You guys are killing me.
Stuff.PK, I only have one question for you: Do you like Neruda?
Foolish guy, the sooner the Drug hit the Market it benefits Takeda as well as AFFY bigtime.
Of course for AFFY that is the only source of income.
For Takeda it is blockbuster and a monopoly due to its patents for the next 15 years. On top of it due to its lowcost mfg process, they can rule for ever.
Mercera can get into US market next year and Takeda needs to position itself ahead.
Sentiment: Strong Buy